Flu deaths trigger rise of biotech stocks

Recent headlines about a cluster of avian flu deaths in Indonesia could be felt among biotech companies working on the virus. A host of stocks, from Novavax to BioCryst to Generex and more, saw their stocks go up as investors reacted to the headlines by buying up shares. Analysts say that every time a new headline hits newspapers and the Internet, we're likely to experience gyrations on the stock market.

- here's the report from the Philadelphia Inquirer

PLUS: The World Health Organization is sending a team of experts to study the cluster. Article

ALSO: The feds say a host of avian flu drugs on the market are fake. Report

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.